Provide the antibody relative to the nonglycosylated glycosylated PD-1 of PD-1 selective bindings. In some respects, the PD-1 polypeptides comprising glycosylated amino acid position are additionally provided. Additionally provide the method for making and using such antibody and polypeptide (for example, for treating cancer).